NFE2L1 and nonpapillary renal cell carcinoma: In summary, our research revealed that NAT10, functioning as a tumor-promoting factor, suppresses ferroptosis in ccRCC via the NFE2L1-GPX4 signaling pathway, thereby facilitating the malignant progression of the disease.